-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Bitte wählen↓
Symbol CIPLA.IS
Portrait der Cipla Aktie
Dir gefallen die Informationen zu Cipla?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Cipla?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Cipla?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Cipla?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
111 News & Informationen zur Cipla Aktie
Sensex, Nifty close marginally lower from record high on profit-taking
Metals, IT lead decliners
Stock market update: Stocks that hit 52-week lows on NSE in today's trade
M&M, Tata Steel, Cipla, Hindalco and Bajaj Finserv were among the top losers on NSE in today's trade.
Sensex, Nifty Give Up Early Gains To End Lower
(RTTNews) – Indian shares ended a tad lower on Wednesday, with metals and information technology companies pacing the declines. After a strong o…
Taking Stock: Sensex, Nifty fail to hold record levels amid profit-booking; realty stocks outshine
More than 200 stocks, including Sobha, SBI Life Insurance Company, ICICI Bank, Divis Laboratories hit a 52-week high on the BSE.
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
Zen Tech, RPG Life Sci, ABB Power, Indian Energy Exchg and Oberoi Realty, hit their fresh 52-week highs during the day.
Sensex off record high, ends 214 pts lower; Nifty below 17,100; M&M sheds 3%
Realty stocks surged as few of them were included in the NSEs F&O segment. Bank and media stocks also continued their rally. IT and metal stocks were under selling pressure.
Share market update: Most active stocks in today's market in terms of volume
The NSE Nifty index closed 55.95 points down at 17076.25
Ami Organics IPO: Reasonable valuation, strong product portfolio; check grey market premium, should you invest
Ami Organics Rs 570-crore IPO is set to open for subscription on 1 September 2021, along with Rs 1,895-crore Vijaya Diagnostic Centre IPO
Taper or no taper, market set to hit an intermediate top: Here are your cues
Even in the absence of so called ‘taper tantrum, if we look at the global scenario in isolation, markets seem to have developed froth with bloated valuations, thereby warranting a major correction as a measure of self-check and a balancing act, if they have to remain in a sustainable bull market for a longer period.
Cipla, Kemwell Biopharma enter JV to develop biosimilars
The two companies will incorporate the JV for this purpose with an aim to enter the respiratory biosimilars space, Cipla said in a regulatory filing
Cipla partners Kemwell to foray into respiratory biosimilars space
Cipla’s respiratory drug prowess combined with Kemwell’s expertise in biologics will accelerate bringing these essential products to market.
Ahead of Market: 12 things that will decide stock action on Wednesday
Mazhar Mohammad of Chartviewindia.in said the index is in a pullback mode, as it sustained above the recent low of 16,376 despite witnessing a sharp correction on August 20.
Stock market update: Nifty Pharma index advances 0.54%
The Nifty Pharma index closed 0.54 per cent up at 14041.25.
Fag-end buying in IT, FMCG stocks lift Sensex by 210 pts; Nifty settles above 16,600 for first time
Buying was seen in IT and FMCG counters, while broader market stocks continued to reel under pressure.
Sensex, Nifty Little Changed In Early Trade
(RTTNews) – Indian shares were flat to slightly higher on Tuesday amid mixed global cues. The benchmark S&P BSE Sensex rose 48 points, or 0.1 pe…
Share market update: Most active stocks of the day in terms of traded value
The NSE Nifty index closed 164.7 points up at 16529.1
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
Shriram City Union, SVP Global, Kovai Medical, Technocraft Ind and Krebs Biochem, hit their fresh 52-week highs during the day.
Sensex Rises 250 Points In Early Trade; Nifty Tops 16,400
(RTTNews) – Indian shares opened on a firm note as investors cheered positive inflation and industrial output data released post-market hours Thur…
Stock market update: Stocks that hit 52-week lows on NSE
Eicher Motors, Dr. Reddys, Sun Pharma, Cipla and Tech Mahindra were among the top losers on NSE.
Cipla Gets FDA Nod For Generic Equivalent Of Novartis' Durezol – Quick Facts
(RTTNews) – Global pharmaceutical company Cipla Limited has received final FDA approval for its Abbreviated New Drug Application for Difluprednate…
Cipla gets USFDA nod for generic product
The company has received final approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Novartis Pharmaceutical Corporation''s Durezol, Cipla said in a statement.
Drug companies see US sales plunging in Q1FY22 amidst pricing pressure, lack of new approvals
Strides Pharma, Cipla among the companies. Strides Pharma reports net loss of Rs 21.23 crore in the first quarter of FY22. MD & CEO says firm has not seen the kind of price erosion it has seen in Q1FY22.
Share market update: Most active stocks of the day in terms of total traded value
The NSE Nifty index was trading 57.15 points down at 16222.95
Stock market update: Stocks that hit 52-week lows on NSE
Sun Pharma, Shree Cements, Tata Consumer, Cipla and Bajaj Auto were among the top losers on NSE.
Sensex gains in early trade, Nifty50 above 16,300; Zomato climbs 3%, Lupin drops 3%
The S&P BSE Sensex index rose as much as 204 points to touch 54,758.74 in the first few minutes of trade, and the broader NSE Nifty50 benchmark climbed to as high as 16,338.75, up 59 points from its previous close.
Cipla CFO says drug maker to outperform domestic market in FY22, Moderna vaccine import may take time
In an interview to Moneycontrol, Cipla's Global Chief Financial Officer Kedar Upadhye expressed confidence that the company will outperform domestic formulation market and clock EBITDA margins of 22.5–23 percent for FY22.
Stock market update: Stocks that hit 52-week lows on NSE
Hindalco, Divis Labs, Tata Consumer, RIL and Cipla were among the top losers on NSE.
Stock market update: Nifty Pharma index falls 0.59% in an upbeat market
The Nifty Pharma index was trading 0.59 per cent down at 14431.75.
Cipla share price tanks 4% post Q1 results; here's what brokerages say
The company posted a net profit of Rs 709.92 crore in the April-June quarter of the current fiscal compared to Rs 566.04 in the same quarter of the previous fiscal
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
PVP Ventures Ltd., Accuracy Shipping, BASF India, Venus Remedies and Gujarat Sidhee, hit their fresh 52-week highs during the day.
Stock market update: Stocks that hit 52-week lows on NSE in today's trade
Cipla, RIL, Shree Cements, UltraTech Cem. and SBI were among the top losers on NSE in today's trade.